Family-based association study of lithium-related and other candidate genes in bipolar disorder.

CONTEXT Association studies in bipolar disorder have been focused on a relatively narrow pool of candidate genes based on a limited understanding of the underlying pathophysiologic features. Recent developments suggest that a broader pool of genes may be associated with this disorder. OBJECTIVE To examine the association between genes related to the lithium mechanism of action, as well as other positional and functional candidates, with bipolar I disorder. DESIGN We examined a dense set of haplotype-tagging single-nucleotide polymorphisms using a gene-based test of association. PARTICIPANTS Three hundred seventy-nine parent-affected offspring trios. RESULTS No genes specifically chosen to probe the action of lithium were associated with bipolar disorder. However, gene-based analysis of sialyltransferase 4A (SIAT4A), tachykinin receptor 1 (TACR1), and gamma-aminobutyric acid(A) beta2 receptor subunit (GABRB2) yielded evidence of association (empirical P value, <.005). Among 3 genes associated with schizophrenia or bipolar disorder in multiple previous studies, including dysbindin (DTNBP1), neuregulin (NRG1), and disrupted-in-schizophrenia 1 (DISC1), only DISC1 showed evidence of association in this cohort. In a secondary analysis of these 6 genes among parent-proband trios with a history of psychosis, evidence of the association with SIAT4A was strengthened. CONCLUSIONS These results suggest novel candidates and 1 gene (DISC1) previously associated with schizophrenia that merit further study in bipolar disorder. However, polymorphisms in major lithium-signaling genes do not appear to contribute substantially to bipolar liability.

[1]  S. Cichon,et al.  A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder , 2008, Molecular Psychiatry.

[2]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[3]  Pak Chung Sham,et al.  WHAP: haplotype-based association analysis , 2007, Bioinform..

[4]  A. Sawa,et al.  Disrupted‐in‐Schizophrenia‐1 (DISC1) , 2006, Annals of the New York Academy of Sciences.

[5]  Mark J Daly,et al.  Analysis of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between reported common variant associations and schizophrenia. , 2006, American journal of human genetics.

[6]  C. Sabatti,et al.  Convergent linkage evidence from two Latin-American population isolates supports the presence of a susceptibility locus for bipolar disorder in 5q31-34. , 2006, Human molecular genetics.

[7]  Mark A Frye,et al.  Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study. , 2006, The Journal of clinical psychiatry.

[8]  D. Altshuler,et al.  Common variants in HNF-1 α and risk of type 2 diabetes , 2006, Diabetologia.

[9]  J. Qin,et al.  SIN1/MIP1 Maintains rictor-mTOR Complex Integrity and Regulates Akt Phosphorylation and Substrate Specificity , 2006, Cell.

[10]  Katsushi Tokunaga,et al.  Association study of the dysbindin (DTNBP1) gene in schizophrenia from the Japanese population , 2006, Neuroscience Research.

[11]  Kristin G Ardlie,et al.  Common Single Nucleotide Polymorphisms in TCF7L2 Are Reproducibly Associated With Type 2 Diabetes and Reduce the Insulin Response to Glucose in Nondiabetic Individuals , 2006, Diabetes.

[12]  K. Sleegers,et al.  Association of brain-specific tryptophan hydroxylase, TPH2, with unipolar and bipolar disorder in a Northern Swedish, isolated population. , 2006, Archives of General Psychiatry.

[13]  D. Collier,et al.  Association of the dysbindin gene with bipolar affective disorder. , 2006, The American journal of psychiatry.

[14]  S. Roche,et al.  First family-based test for association of neuregulin with bipolar affective disorder , 2006, Molecular Psychiatry.

[15]  I. Sora,et al.  Association Between Polymorphisms in the Promoter Region of the Sialyltransferase 8B (SIAT8B) Gene and Schizophrenia , 2006, Biological Psychiatry.

[16]  W. Liu,et al.  Association analyses of the neuregulin 1 gene with schizophrenia and manic psychosis in a Hispanic population , 2006, Acta psychiatrica Scandinavica.

[17]  Bradley M. Hemminger,et al.  TAMAL: an integrated approach to choosing SNPs for genetic studies of human complex traits , 2006, Bioinform..

[18]  Jarmo Hietala,et al.  Lack of Efficacy of the Substance P (Neurokinin1 Receptor) Antagonist Aprepitant in the Treatment of Major Depressive Disorder , 2006, Biological Psychiatry.

[19]  E. Eskin,et al.  Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples , 2006, Molecular Psychiatry.

[20]  S. Claes,et al.  Patient-control association study of substance P-related genes in unipolar and bipolar affective disorders. , 2005, The international journal of neuropsychopharmacology.

[21]  S Purcell,et al.  Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia , 2005, Molecular Psychiatry.

[22]  S. Gabriel,et al.  Efficiency and power in genetic association studies , 2005, Nature Genetics.

[23]  R. Myers,et al.  Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Daly,et al.  Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. , 2005, American journal of human genetics.

[25]  G. Kirov,et al.  Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. , 2005, Archives of general psychiatry.

[26]  B. Dean,et al.  Changes in hippocampal GABAA receptor subunit composition in bipolar 1 disorder. , 2005, Brain research. Molecular brain research.

[27]  P. Keck,et al.  The Texas implementation of medication algorithms update for treatment of bipolar I disorder. , 2005, The Journal of clinical psychiatry.

[28]  Joseph R Calabrese,et al.  The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. , 2005, The Journal of clinical psychiatry.

[29]  N. Wray,et al.  Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population , 2005, Molecular Psychiatry.

[30]  G. Kirov,et al.  Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. , 2005, Archives of general psychiatry.

[31]  Olga V. Demler,et al.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[32]  B. Czéh,et al.  Chronic psychosocial stress in tree shrews: effect of the substance P (NK1 receptor) antagonist L-760735 and clomipramine on endocrine and behavioral parameters , 2005, Psychopharmacology.

[33]  Ivan Nikolov,et al.  Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1) , 2005, Biological Psychiatry.

[34]  S. Faraone,et al.  Meta‐analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[35]  M. Webster,et al.  Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains , 2005, Biological Psychiatry.

[36]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[37]  A. Lajtha,et al.  Reduced [3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: Is selective loss of glutamatergic neurons associated with major psychoses? , 1993, Neurochemical Research.

[38]  S. Purcell,et al.  Support for involvement of neuregulin 1 in schizophrenia pathophysiology , 2005, Molecular Psychiatry.

[39]  A. Nierenberg,et al.  Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). , 2004, The American journal of psychiatry.

[40]  P. Visscher,et al.  A genome scan and follow-up study identify a bipolar disorder susceptibility locus on chromosome 1q42 , 2004, Molecular Psychiatry.

[41]  W Hennah,et al.  Replication of 1q42 linkage in Finnish schizophrenia pedigrees , 2004, Molecular Psychiatry.

[42]  H. Möller,et al.  SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression , 2004, Molecular Psychiatry.

[43]  David Goldman,et al.  Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. , 2004, American journal of human genetics.

[44]  N. Schork,et al.  Candidate genes, pathways and mechanisms for bipolar (manic–depressive) and related disorders: an expanded convergent functional genomics approach , 2004, Molecular Psychiatry.

[45]  Andrew L. Lemire,et al.  The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells , 2004, Journal of neurochemistry.

[46]  T. Asada,et al.  Immunohistochemical and immunoblot study of GABAA α1 and β2/3 subunits in the prefrontal cortex of subjects with schizophrenia and bipolar disorder , 2004, Neuroscience Research.

[47]  A. Stoll,et al.  Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder , 2004, Biological Psychiatry.

[48]  P. Sham,et al.  The future of association studies: gene-based analysis and replication. , 2004, American journal of human genetics.

[49]  J. Woodgett,et al.  Glycogen Synthase Kinase-3β Haploinsufficiency Mimics the Behavioral and Molecular Effects of Lithium , 2004, The Journal of Neuroscience.

[50]  G. Andrews,et al.  Twelve-month prevalence and disability of DSM-IV bipolar disorder in an Australian general population survey , 2004, Psychological Medicine.

[51]  H. Xue,et al.  Association of SNPs and haplotypes in GABAA receptor β2 gene with schizophrenia , 2004, Molecular Psychiatry.

[52]  M. Daly,et al.  Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region. , 2004, Diabetes.

[53]  Monika Milewski,et al.  Decoding randomly ordered DNA arrays. , 2004, Genome research.

[54]  W. Ho,et al.  Li+ enhances GABAergic inputs to granule cells in the rat hippocampal dentate gyrus , 2004, Neuropharmacology.

[55]  M. Alda,et al.  Identification of Lithium-Regulated Genes in Cultured Lymphoblasts of Lithium Responsive Subjects with Bipolar Disorder , 2004, Neuropsychopharmacology.

[56]  P. Schulz,et al.  Clonazepam and lorazepam in acute mania: a Bayesian meta-analysis. , 2004, Journal of affective disorders.

[57]  M. Daly,et al.  Genome-wide scan in Portuguese Island families identifies 5q31–5q35 as a susceptibility locus for schizophrenia and psychosis , 2004, Molecular Psychiatry.

[58]  M. Karayiorgou,et al.  Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia , 2004, Nature Genetics.

[59]  D. Lewis,et al.  Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction , 2004, Psychopharmacology.

[60]  Thomas G Schulze,et al.  The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. , 2003, American journal of human genetics.

[61]  Leena Peltonen,et al.  Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. , 2003, Human molecular genetics.

[62]  Peter B. Jones,et al.  Oligodendrocyte dysfunction in schizophrenia and bipolar disorder , 2003, The Lancet.

[63]  A. Caspi,et al.  Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene , 2003, Science.

[64]  A. Sampson,et al.  Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia , 2003, The Journal of Neuroscience.

[65]  E. Loetscher,et al.  GAD67: the link between the GABA-deficit hypothesis and the dopaminergic- and glutamatergic theories of psychosis , 2003, Journal of Neural Transmission.

[66]  Leena Peltonen,et al.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. , 2003, American journal of human genetics.

[67]  H. Pétursson,et al.  Genome scan of pedigrees multiply affected with bipolar disorder provides further support for the presence of a susceptibility locus on chromosome 12q23‐q24, and suggests the presence of additional loci on 1p and 1q , 2003, Psychiatric genetics.

[68]  S. Christian,et al.  Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series. , 2003, American journal of human genetics.

[69]  Margot Albus,et al.  Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. , 2003, American journal of human genetics.

[70]  H. Hwu,et al.  Linkage of schizophrenia with chromosome 1q loci in Taiwanese families , 2003, Molecular Psychiatry.

[71]  Pak Chung Sham,et al.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits , 2003, Bioinform..

[72]  M. Alda,et al.  Is response to prophylactic lithium a familial trait? , 2002, The Journal of clinical psychiatry.

[73]  P. Muglia,et al.  The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. , 2002, American journal of human genetics.

[74]  R. Straub,et al.  Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. , 2002, American journal of human genetics.

[75]  Jürg Ott,et al.  Set association analysis of SNP case-control and microarray data , 2002, RECOMB '02.

[76]  Takanobu Nakazawa,et al.  Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation , 2002, Journal of neurochemistry.

[77]  M. Thase,et al.  Practice guideline for the treatment of patients with bipolar disorder (revision). , 2002, The American journal of psychiatry.

[78]  J. Kane,et al.  Extending indications for long-term pharmacotherapy: opportunities and challenges. , 2002, The American journal of psychiatry.

[79]  S. Gabriel,et al.  Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus , 2002, Molecular Psychiatry.

[80]  C. Phiel,et al.  Molecular targets of lithium action. , 2003, Annual review of pharmacology and toxicology.

[81]  Vishwajit L. Nimgaonkar,et al.  A mannosyltransferase gene at 11q23 is disrupted by a translocation breakpoint that co-segregates with bipolar affective disorder in a small family , 2002, Neurogenetics.

[82]  M. Guenther,et al.  Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen* , 2001, The Journal of Biological Chemistry.

[83]  J S Sinsheimer,et al.  Chromosome 1 loci in Finnish schizophrenia families. , 2001, Human molecular genetics.

[84]  大沼 徹.  Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia : focus on GABA content,GABAA receptor α-1 subunit messenger RNA and human GABA transporter-1 (hGAT-1) messenger RNA expression , 2001 .

[85]  D. Curtis,et al.  Multimarkerhaplotypes within the serotonin transporter gene suggest evidence of an association with bipolar disorder. , 2000, American journal of medical genetics.

[86]  Eric S. Lander,et al.  The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes , 2000, Nature Genetics.

[87]  Martin S. Taylor,et al.  Disruption of two novel genes by a translocation co-segregating with schizophrenia. , 2000, Human molecular genetics.

[88]  Stephen P. Hunt,et al.  Rewarding effects of opiates are absent in mice lacking the receptor for substance P , 2000, Nature.

[89]  D. Lewis.  GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia , 2000, Brain Research Reviews.

[90]  Paul J. Harrison,et al.  Substance P (NK1) receptors in the cingulate cortex in unipolar and bipolar mood disorder and schizophrenia , 2000, Biological Psychiatry.

[91]  B. Gumbiner,et al.  A Cell-Free Assay System for β-Catenin Signaling That Recapitulates Direct Inductive Events in the Early Xenopus laevis Embryo , 1999, The Journal of cell biology.

[92]  S. Detera-Wadleigh,et al.  Radiation hybrid mapping of genes in the lithium-sensitive Wnt signaling pathway , 1999, Molecular Psychiatry.

[93]  J. Kleinman,et al.  Alterations of hippocampal secreted N-CAM in bipolar disorder and synaptophysin in schizophrenia , 1999, Molecular Psychiatry.

[94]  D. Chuang,et al.  Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[95]  M. Eames,et al.  Loss of a prolyl oligopeptidase confers resistance to lithium by elevation of inositol (1,4,5) trisphosphate , 1999, The EMBO journal.

[96]  L R Goldin,et al.  A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[97]  M. Alda.  Pharmacogenetics of lithium response in bipolar disorder. , 1999, Journal of psychiatry & neuroscience : JPN.

[98]  R. Murray,et al.  Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. , 1999, Archives of general psychiatry.

[99]  Molly M. Huntsman,et al.  Altered ratios of alternatively spliced long and short γ2 subunit mRNAs of the γ-amino butyrate type A receptor in prefrontal cortex of schizophrenics , 1998 .

[100]  R G Hill,et al.  Distinct mechanism for antidepressant activity by blockade of central substance P receptors. , 1998, Science.

[101]  D. Easton,et al.  Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. , 1998, American journal of medical genetics.

[102]  P. Salinas,et al.  WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons. , 1997, Developmental biology.

[103]  B S Weir,et al.  Tests for linkage and association in nuclear families. , 1997, American journal of human genetics.

[104]  C. Hammen,et al.  Stress reactivity in bipolar patients and its relation to prior history of disorder. , 1997, The American journal of psychiatry.

[105]  John P. Rice,et al.  Initial genomic scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 3, 5, 15, 16, 17, and 22. , 1997, American journal of medical genetics.

[106]  P. S. Klein,et al.  Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. , 1997, Developmental biology.

[107]  R. Adolfsson,et al.  Relationship between prophylactic effect of lithium therapy and family history of affective disorders , 1995, Biological Psychiatry.

[108]  James R. Woodgett,et al.  Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cells , 1996, Current Biology.

[109]  W J Ewens,et al.  The TDT and other family-based tests for linkage disequilibrium and association. , 1996, American journal of human genetics.

[110]  D. Melton,et al.  A molecular mechanism for the effect of lithium on development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[111]  S. Akbarian,et al.  GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. , 1995, Cerebral cortex.

[112]  J. Nurnberger,et al.  Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. , 1994, Archives of general psychiatry.

[113]  M. Alda,et al.  Lithium response and genetics of affective disorders. , 1994, Journal of affective disorders.

[114]  T. Magnuson,et al.  N-CAM mutation inhibits tangential neuronal migration and is phenocopied by enzymatic removal of polysialic acid , 1994, Neuron.

[115]  H. Kitagawa,et al.  Differential expression of five sialyltransferase genes in human tissues. , 1994, The Journal of biological chemistry.

[116]  H. Kitagawa,et al.  Cloning of a novel alpha 2,3-sialyltransferase that sialylates glycoprotein and glycolipid carbohydrate groups. , 1994, The Journal of biological chemistry.

[117]  Michael J. Berridge,et al.  Neural and developmental actions of lithium: A unifying hypothesis , 1989, Cell.

[118]  D. Garver,et al.  Familial differences in lithium responsive versus lithium nonresponsive psychoses. , 1985, Journal of psychiatric research.

[119]  J. Nurnberger,et al.  A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. , 1982, Archives of general psychiatry.

[120]  B. Burns,et al.  “Lithum non‐responders” in a lithium clinic , 1977, Acta psychiatrica Scandinavica.

[121]  J. Fleiss,et al.  Lithium Carbonate Prophylaxis Failure , 1976, British Journal of Psychiatry.

[122]  R. Fieve,et al.  Relationship between the effectiveness of lithium therapy and family history. , 1973, The American journal of psychiatry.